Washington State Prescription Drug Transparency Reporting: PBMs

Having trouble viewing this email? View it as a Web page.

Health Care Authority (HCA) logo

Washington State Prescription Drug Transparency Reporting: PBMs

The Health Care Authority (HCA) is writing you to pass along important information pertaining to your role in the prescription drug price transparency program, and to extend our sincere thanks to those who participated in our listening sessions. Your feedback and voice is critical to building a functioning and reasonable reporting program.

Why am I receiving this?

The Washington State Prescription Drug Transparency Reporting program requires reporting from carriers, pharmacy benefit managers, drug manufacturers, and pharmacy service administrative organizations.

You are receiving this because either:

  • We have identified your organization as a required pharmacy benefit manager (PBM) data submitter under this legislative mandate. Or,
  • You signed up for PBM updates on the drug price transparency website. If you are not the representative of a required submitter please:
    • Click unsubscribe at the bottom of this alert. You will be removed from this targeted distribution list, but will still receive general information updates.
    • Disregard the rest of this notification.

If you believe you have received this notification in error, and you are exempt from reporting, please email HCA.

What do I need to do?

PBMs are not required to submit data until March 1, 2021, so there is no data needed from you at this time. We will send a notification letter to you when we start the registration process for PBMs.

What can I expect next?

You will receive a series of letters from us identifying next steps and delivering tools such as:

  • Registration Process
  • Data definitions
  • Data submission guide
  • Data submittal instructions

Questions?

HCA has created a drug price transparency webpage where you can stay connected with recent updates and contact us.